Background Within the last two decades mesenchymal stem cells (MSCs) have been pre-clinically utilized in the treatment of a variety of kinds of diseases including chronic obstructive pulmonary disease (COPD). adopted to assess the effect size. Random effect model was used due to the heterogeneity between the studies. A total of 20 eligible studies were… Continue reading Background Within the last two decades mesenchymal stem cells (MSCs) have